These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 8154998)
1. [Scintigraphy of myocardial perfusion combined with pharmacologic stress with dipyridamole]. Chalela WA; Cruz SH; Moraes AP; Soares Júnior J; Giorgi MC; Izaki M; Moffa PJ; Cerri GG; Bellotti G; Pileggi F Arq Bras Cardiol; 1993 Oct; 61(4):207-11. PubMed ID: 8154998 [TBL] [Abstract][Full Text] [Related]
2. Safety and clinical utility of combined intravenous dipyridamole/symptom-limited exercise stress test with thallium-201 imaging in patients with known or suspected coronary artery disease. Ignaszewski AP; McCormick LX; Heslip PG; McEwan AJ; Humen DP J Nucl Med; 1993 Dec; 34(12):2053-61. PubMed ID: 8254386 [TBL] [Abstract][Full Text] [Related]
3. Comparison of adenosine triphosphate and dipyridamole in diagnosis by thallium-201 myocardial scintigraphy. Watanabe K; Sekiya M; Ikeda S; Miyagawa M; Kinoshita M; Kumano S J Nucl Med; 1997 Apr; 38(4):577-81. PubMed ID: 9098205 [TBL] [Abstract][Full Text] [Related]
4. Dipyridamole-induced ST segment depression during thallium-201 imaging in patients with coronary artery disease: angiographic and hemodynamic determinants. Chambers CE; Brown KA J Am Coll Cardiol; 1988 Jul; 12(1):37-41. PubMed ID: 3379218 [TBL] [Abstract][Full Text] [Related]
5. [Diagnosis of chronic coronary failure by clinical aspects, ECG and myocardial scintigraphy after infusion of isoprenaline. Comparison with coronarography]. Pezard P; Geslin P; L'Hoste P; Lejeune JJ; Victor J; Vilayleck S; Jallet P; Tadei A Ann Cardiol Angeiol (Paris); 1989 Mar; 38(3):163-70. PubMed ID: 2735731 [TBL] [Abstract][Full Text] [Related]
6. Noninvasive detection of coronary artery disease by myocardial imaging with thallium-201--the significance of pharmacologic interventions. Narita M; Kurihara T; Usami M Jpn Circ J; 1981 Jan; 45(1):127-40. PubMed ID: 6779029 [TBL] [Abstract][Full Text] [Related]
7. Dipyridamole thallium testing: noncardiac side effects, cardiac effects, electrocardiographic changes and hemodynamic changes after dipyridamole infusion with and without exercise. Laarman GJ; Niemeyer MG; van der Wall EE; Verzijlbergen FJ; Go TL; Bruschke AV; Ascoop CA Int J Cardiol; 1988 Aug; 20(2):231-8. PubMed ID: 3209253 [TBL] [Abstract][Full Text] [Related]
9. Assessment of the severity of coronary artery disease by thallium-201 washout rate after dipyridamole infusion--a coronary hemodynamic and metabolic study. Tamoto S; Ishihara T; Kojima S; Hosokawa H; Ohkubo T; Ohtuji S; Fukai M; Takada K; Seki I; Ohsawa N Jpn Circ J; 1995 Jan; 59(1):11-22. PubMed ID: 7752441 [TBL] [Abstract][Full Text] [Related]
10. [Assessment of coronary stenosis by myocardial scintigraphy with thallium-201 after dipyridamol infusion]. Pirelli S; Inglese E; Suppa M; Corrada E; Piccalò G; Campolo L; Carù B G Ital Cardiol; 1985 May; 15(5):520-5. PubMed ID: 4054490 [TBL] [Abstract][Full Text] [Related]
11. Safety of pharmacological (intravenous dipyridamole) stress for Thallium-201 perfusion imaging in patients with coronary artery disease unable to exercise. Zaman M; Hashmi R; Niaz K; Ahmad A; Kamal S J Pak Med Assoc; 1994 Oct; 44(10):237-9. PubMed ID: 7815687 [TBL] [Abstract][Full Text] [Related]